Literature DB >> 25081988

Comparisons between patients with trimethoprim-sulfamethoxazole-susceptible and trimethoprim-sulfamethoxazole-resistant Stenotrophomonas maltophilia monomicrobial bacteremia: A 10-year retrospective study.

Ching-Hsun Wang1, Jung-Chung Lin1, Hsin-An Lin1, Feng-Yee Chang1, Ning-Chi Wang1, Sheng-Kang Chiu1, Te-Yu Lin1, Ya-Sung Yang1, Li-Ping Kan1, Chin-Hsuan Yang1, Ming-Chin Chan2, Kuo-Ming Yeh3.   

Abstract

BACKGROUND/
PURPOSE: The impact of bacteremia due to the resistance of Stenotrophomonas maltophilia to trimethoprim-sulfamethoxazole (TMP-SXT) is uncertain. This study compared the clinical characteristics and outcomes of patients with TMP-SXT-susceptible (TSSSM) and TMP-SXT-resistant S. maltophilia (TSRSM) monomicrobial bacteremia.
METHODS: The medical records of adult patients with TSSSM and TSRSM monomicrobial bacteremia from January 2004 to December 2013 were reviewed and classified into two groups, namely, TSSSM and TSRSM.
RESULTS: There were 184 patients with monomicrobial S. maltophilia bacteremia. The mean age was 68.3 years. Most patients were males (72.8%), had high Charlson Comorbidity Index scores, previously prescribed antimicrobial agents, and indwelling medical devices. The 14-day and in-hospital mortality rates were 23.9% and 47.2%, respectively. There were 128 patients (69.6%) with TSSSM and 56 (30.4%) with TSRSM. The incidence of TSSSM bacteremia increased during the study period. The TSSSM and TSRSM groups had similar demographic and clinical characteristics and no significant differences in 14-day and in-hospital mortality (24.2% vs. 23.2%, p = 0.833; 50.0% vs. 41.1%, p = 0.264, respectively). Patients with TSSSM bacteremia had an increased risk of septic shock (p = 0.044) and neutropenia (p = 0.028) at bacteremia onset. Logistic regression analysis indicated that acquisition of TMP-SXT resistance was an independent risk factor for prolonged hospitalization (p = 0.018) and catheter-related S. maltophilia bacteremia was inversely associated with prolonged hospitalization after bacteremia (p = 0.032).
CONCLUSION: There were no significant differences in mortality for patients with TSSSM and TSRSM bacteremia, but patients with TSRSM bacteremia were associated with prolonged hospitalization after bacteremia onset.
Copyright © 2014. Published by Elsevier B.V.

Entities:  

Keywords:  Stenotrophomonas maltophilia; bacteremia; resistance; trimethoprim–sulfamethoxazole

Mesh:

Substances:

Year:  2014        PMID: 25081988     DOI: 10.1016/j.jmii.2014.06.005

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  9 in total

1.  Stenotrophomonas maltophilia bacteremia and pneumonia at a tertiary-care oncology center: a review of 16 years.

Authors:  Consuelo Velázquez-Acosta; Sugehily Zarco-Márquez; Mari Carmen Jiménez-Andrade; Patricia Volkow-Fernández; Patricia Cornejo-Juárez
Journal:  Support Care Cancer       Date:  2018-01-07       Impact factor: 3.603

2.  The efflux pump SmeDEF contributes to trimethoprim-sulfamethoxazole resistance in Stenotrophomonas maltophilia.

Authors:  María Blanca Sánchez; José Luis Martínez
Journal:  Antimicrob Agents Chemother       Date:  2015-04-27       Impact factor: 5.191

3.  Overexpression of the Efflux Pumps SmeVWX and SmeDEF Is a Major Cause of Resistance to Co-trimoxazole in Stenotrophomonas maltophilia.

Authors:  María Blanca Sánchez; José Luis Martínez
Journal:  Antimicrob Agents Chemother       Date:  2018-05-25       Impact factor: 5.191

4.  Standard susceptibility testing overlooks potent azithromycin activity and cationic peptide synergy against MDR Stenotrophomonas maltophilia.

Authors:  Monika Kumaraswamy; Leo Lin; Joshua Olson; Ching-Fang Sun; Poochit Nonejuie; Ross Corriden; Simon Döhrmann; Syed Raza Ali; Deirdre Amaro; Manfred Rohde; Joe Pogliano; George Sakoulas; Victor Nizet
Journal:  J Antimicrob Chemother       Date:  2016-01-31       Impact factor: 5.790

5.  Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia infections.

Authors:  Priyam Batra; Purva Mathur; Mahesh C Misra
Journal:  J Lab Physicians       Date:  2017 Apr-Jun

6.  Stenotrophomonas Bacteremia Antibiotic Susceptibility and Prognostic Determinants: Mayo Clinic 10-Year Experience.

Authors:  Ahmed M Hamdi; Madiha Fida; Omar M Abu Saleh; Elena Beam
Journal:  Open Forum Infect Dis       Date:  2020-01-19       Impact factor: 3.835

Review 7.  Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options.

Authors:  Ya-Ting Chang; Chun-Yu Lin; Yen-Hsu Chen; Po-Ren Hsueh
Journal:  Front Microbiol       Date:  2015-09-02       Impact factor: 5.640

8.  Phenotypic and Molecular Characteristics of the MDR Efflux Pump Gene-Carrying Stenotrophomonas maltophilia Strains Isolated in Warsaw, Poland.

Authors:  Olga M Zając; Stefan Tyski; Agnieszka E Laudy
Journal:  Biology (Basel)       Date:  2022-01-10

9.  Characteristics of Stenotrophomonas maltophilia infection in children in Sichuan, China, from 2010 to 2017.

Authors:  Lili Wang; Wei Zhou; Yang Cao; Chunsong Yang; Hanmin Liu; Ting Chen; Lina Chen
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.